NYSE · Specialty Business Services

Attovia Therapeutics, Inc. (ATTO) Stock

$16.52 +1.32% NYSE: ATTO Industrials

Valuation

MetricValue
Price$16.52
Market Cap$711.05M
P/E Ratio-23.81
P/B Ratio8.96
P/S Ratio2117.08
EPS (TTM)$-6.41
52-Week High$28.00
52-Week Low$15.58
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-32.05%
ROA-30.65%
ROCE-36.08%
Gross Margin93.53%
Operating Margin5.00%
Net Margin-6.21%
Debt/Equity0.04
Current Ratio1.24

Annual Financials (USD)

Metric20172018201920202021
Revenue$1.9B$1.8B$1.7B$1.4B$1.4B
Operating Profit$92.0M$90.0M$64.0M$56.0M$73.0M
Net Profit$-17.0M$19.0M$-81.0M$-47.0M$-90.0M
EPS$-1.14$1.24$-5.59$-3.32$-6.41
Op Margin4.8%4.9%3.7%4.0%5.0%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$1.3B$1.2B$1.3B$1.2B$1.1B
Total Liabilities$953.0M$873.0M$1.1B$1.1B$1.1B
Cash$142.0M$134.0M$125.0M$209.0M$129.0M
Borrowings$486.0M$460.0M$721.0M$727.0M$718.0M

Latest News

Omilia Appoints Armando Trivellato as EVP Growth Latin America and Iberia Business Wire · Jul 2, 2026 Atento and Cresta Sign Strategic Partnership to Deliver Hybrid Human-AI Customer Experience Solutions PR Newswire · May 7, 2026

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$114.0M$81.0M$46.0M$128.0M$42.0M
Investing Cash Flow$-168.0M$-81.0M$-96.0M$-76.0M$-99.0M
Financing Cash Flow$-60.0M$-40.0M$-6.0M$-2.0M$-59.0M
Net Cash Flow$-52.0M$-8.0M$-9.0M$84.0M$-80.0M
Free Cash Flow$38.0M$41.0M$6.0M$90.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.29
EV / EBITDA-22.39
FCF Yield-3.70%
Quick Ratio9.39
Interest Coverage0.79
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.71 -1.09% 38.93 $4.95T 0.32%
MSFTMicrosoft Corporation $535.72 +2.51% 28.68 $3.98T 0.76%
GOOGLAlphabet Inc. $352.57 +1.23% 16.94 $4.27T 0.26%
AMZNAmazon.com, Inc. $262.61 +3.37% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $719.65 -0.17% 27.93 $1.83T 0.28%

About Attovia Therapeutics, Inc.

Attovia Therapeutics, Inc. is headquartered in LU.

Attovia Therapeutics, Inc. (ATTO) stock trades at $16.52 with a market capitalization of $711.05M. The stock is valued at a price-to-earnings (P/E) ratio of -23.81, price-to-book of 8.96, price-to-sales of 2117.08. Over the past 52 weeks the stock has ranged between $15.58 and $28.00, and currently trades 41.0% below its 52-week high.

On profitability, Attovia Therapeutics, Inc. generates a return on equity (ROE) of -32.05%, return on capital employed of -36.08%, an operating margin of 5.00%, a net profit margin of -6.21%.

Related Industrials Stocks

SPCX Space Exploration Technologies Corp. $161.69 +0.70% CAT Caterpillar, Inc. $801.57 +0.68% GE GE Aerospace $307.96 +0.77% RTX RTX Corporation $185.87 +0.84% DE Deere & Company $624.59 -4.29% ETN Eaton Corporation, PLC $430.52 +1.42% UNP Union Pacific Corporation $279.08 +0.31% BA Boeing Company (The) $190.38 +1.40% PH Parker-Hannifin Corporation $961.24 +1.51% LMT Lockheed Martin Corporation $508.97 +0.21% ADP Automatic Data Processing, Inc. $271.95 +0.45% TT Trane Technologies plc $482.26 +2.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Industrials StocksLow P/E Industrials StocksHigh Net Margin Industrials StocksDividend Industrials StocksLow Debt Industrials StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides